Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.4.3 and removed the v3.4.2 entry in the study record's history.
    Difference
    0.1%
    Check dated 2026-03-08T02:32:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added revision entry v3.4.2 and removed v3.4.1 in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T13:47:41.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Record History shows a new Revision: v3.4.1 added and Revision: v3.4.0 removed.
    Difference
    0.1%
    Check dated 2026-02-07T08:22:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The updates are UI and metadata changes: a Show glossary option, color-coded highlights, and a new revision label (v3.4.0) replacing v3.3.4. They do not modify core study data or page content.
    Difference
    1%
    Check dated 2026-01-24T01:40:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    New revision v3.3.4 appears in the Record History, replacing the previous v3.3.3. This is a routine maintenance update to the page history and does not alter trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T23:13:55.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision history now shows the addition of v3.3.3 and the removal of v3.3.2, as well as the HHS Vulnerability Disclosure entry. This is a routine metadata update and does not affect study data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-19T13:00:35.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.